Fiduciary Trust CO Novo Nordisk A S Transaction History

Fiduciary Trust CO

  • $6.98 Billion
  • Q3 2024

A detailed history of Fiduciary Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Fiduciary Trust CO holds 198,679 shares of NVO stock, worth $20.6 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
198,679
Previous 201,274 1.29%
Holding current value
$20.6 Million
Previous $28.7 Million 17.66%
% of portfolio
0.34%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $308,986 - $377,364
-2,595 Reduced 1.29%
198,679 $23.7 Million
Q2 2024

Aug 14, 2024
SELL
$122.71 - $146.91 $787,798 - $943,162
-6,420 Reduced 3.09%
201,274 $28.7 Million
Q1 2024

May 13, 2024
SELL
$102.11 - $135.92 $197,072 - $262,325
-1,930 Reduced 0.92%
207,694 $26.7 Million
Q4 2023

Feb 12, 2024
SELL
$87.78 - $105.45 $129,914 - $156,066
-1,480 Reduced 0.7%
209,624 $21.7 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $9.46 Million - $20.8 Million
104,003 Added 97.11%
211,104 $19.2 Million
Q2 2023

Aug 01, 2023
SELL
$155.98 - $172.65 $173,449 - $191,986
-1,112 Reduced 1.03%
107,101 $17.3 Million
Q1 2023

May 15, 2023
SELL
$132.34 - $159.14 $62,332 - $74,954
-471 Reduced 0.43%
108,213 $17.2 Million
Q4 2022

Feb 13, 2023
SELL
$102.55 - $135.33 $75,681 - $99,873
-738 Reduced 0.67%
108,684 $14.7 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $97,185 - $119,268
-1,020 Reduced 0.92%
109,422 $10.9 Million
Q2 2022

Aug 12, 2022
SELL
$103.24 - $121.81 $237,142 - $279,797
-2,297 Reduced 2.04%
110,442 $12.3 Million
Q1 2022

May 12, 2022
SELL
$93.1 - $112.54 $36,122 - $43,665
-388 Reduced 0.34%
112,739 $12.5 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $97,701 - $119,304
-1,019 Reduced 0.89%
113,127 $12.7 Million
Q3 2021

Nov 12, 2021
SELL
$84.42 - $106.62 $514,708 - $650,062
-6,097 Reduced 5.07%
114,146 $11 Million
Q2 2021

Aug 16, 2021
SELL
$67.66 - $84.76 $1.38 Million - $1.72 Million
-20,347 Reduced 14.47%
120,243 $10.1 Million
Q1 2021

May 19, 2021
SELL
$67.06 - $75.82 $211,909 - $239,591
-3,160 Reduced 2.2%
140,590 $9.48 Million
Q4 2020

Jan 26, 2021
SELL
$63.89 - $73.8 $596,988 - $689,587
-9,344 Reduced 6.1%
143,750 $10 Million
Q3 2020

Nov 13, 2020
SELL
$63.69 - $70.22 $95,216 - $104,978
-1,495 Reduced 0.97%
153,094 $10.6 Million
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $139,149 - $161,493
-2,377 Reduced 1.51%
154,589 $10.1 Million
Q1 2020

May 15, 2020
SELL
$49.46 - $64.78 $2,967 - $3,886
-60 Reduced 0.04%
156,966 $9.45 Million
Q4 2019

Feb 04, 2020
SELL
$49.86 - $58.26 $130,882 - $152,932
-2,625 Reduced 1.64%
157,026 $9.09 Million
Q3 2019

Nov 12, 2019
SELL
$47.54 - $53.43 $306,775 - $344,783
-6,453 Reduced 3.88%
159,651 $8.25 Million
Q2 2019

Aug 14, 2019
SELL
$46.79 - $52.47 $129,514 - $145,236
-2,768 Reduced 1.64%
166,104 $8.48 Million
Q1 2019

May 07, 2019
SELL
$46.36 - $52.63 $150,391 - $170,731
-3,244 Reduced 1.88%
168,872 $8.83 Million
Q4 2018

Jan 29, 2019
SELL
$41.54 - $47.25 $83,910 - $95,445
-2,020 Reduced 1.16%
172,116 $7.93 Million
Q3 2018

Nov 13, 2018
SELL
$46.76 - $51.24 $91,182 - $99,918
-1,950 Reduced 1.11%
174,136 $8.21 Million
Q2 2018

Aug 03, 2018
SELL
$44.29 - $50.42 $95,223 - $108,403
-2,150 Reduced 1.21%
176,086 $8.12 Million
Q1 2018

May 08, 2018
SELL
$48.49 - $58.14 $202,445 - $242,734
-4,175 Reduced 2.29%
178,236 $8.78 Million
Q4 2017

Jan 29, 2018
SELL
$47.53 - $53.73 $95,345 - $107,782
-2,006 Reduced 1.09%
182,411 $9.79 Million
Q3 2017

Nov 02, 2017
BUY
$41.15 - $49.22 $7.59 Million - $9.08 Million
184,417
184,417 $8.88 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email